航宇微(300053.SZ):玉龍810開發板及芯片經過客户的大量測試和驗證,得到好評,並實現了銷售合同的逐步簽訂
格隆匯7月21日丨有投資者向航宇微(300053.SZ)提問,“公司玉龍810A芯片有沒有簽訂單?有的話主要是哪些行業的客户?”
航宇微回覆稱,公司自主研製的玉龍810芯片為通用AI芯片,可面向航空航天、智能安防、機器人、AIoT、智能製造、智慧交通等應用場景;產品的具體使用場景由客户根據自身的需求確定。目前,玉龍810開發板及芯片經過客户的大量測試和驗證,得到了好評,並實現了銷售合同的逐步簽訂。公司經營、業務及產品有關情況歡迎查閲公司已披露的定期報吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.